Current Clinical Trials at UIHC
Breast Cancer Protocols
GI Oncology Protocols
James R.
Howe, M.D.
Department of Surgery
The University of Iowa Hospitals and Clinics
The objective of this presentation is to discuss the currently
available clinical trials at UIHC in the areas of breast and GI
oncology (August 1996). This includes trials in the CALGB and NSABP
cooperative oncology groups, which are summarized under the following
sections. These summaries are merely overviews of these trials, and
for more specific information please contact Dr. James Howe
(319)356-7945 or Dr. Gerry Clamon (319)356-1932 for CALGB trials, or
Dr. Peter Jochimsen (319)356-3584 for NSABP trials.
Table of Contents
Breast Cancer
A. Overview of Breast Cancer Trials
at UIHC
B. Occult Breast Ca.
- NSABP Breast Protocol B-21
C. Palpable Breast Ca.
- NSABP Breast Protocol B-27
D. Positive Nodes
- CALGB Breast Protocol 9344
- NSABP Breast Protocol B-28
E. High Risk for Systemic Recurrence
- CALGB Breast Protocol 9394
F. 10 or more Positive Nodes
- CALGB Breast Protocol 9082
G. Metastatic, Recurrent, Inoperable
Breast Ca.
- CALGB Breast Protocol 9342
- NSABP Breast Protocol B-26
H. Breast Cancer Prevention
Trial
- NSABP Breast Protocol P-1
II. GI Oncology
A. Overview of GI Clinical Cancer
Trials at UIHC
B. Resected Gastric Ca.
- CALGB GI Protocol 9195
C. Colon Cancer
D. Laparoscopic Colectomy
- CALGB GI Protocol 9396
E. Dukes B3 and C Colorectal Ca.
- CALGB GI Protocol 9395
F. Prevention of Metachronous
Colorectal Ca.
- CALGB GI Protocol 9270
G. Unresectable Metastatic Colorectal
Ca.
- CALGB GI Protocol 9481
H. Rectal Cancer
- NSABP Rectal Protocol R-03
I. High Risk Anal Cancer
- CALGB GI Protocol 9281
University of
Iowa Hospitals and Clinics, Division of Surgical Oncology
Next Page |
Previous Page | Section Top | Title Page